Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
Elevance Health (ELV) saw its stock fall during the first quarter of 2026, detracting from the performance of Heartland Advisors' Opportunistic Value Equity Strategy, despite the strategy outperforming its benchmark. The healthcare sector faced challenges like elevated utilization and medical cost inflation, impacting ELV's margins. However, Heartland Advisors views Elevance Health as a strong long-term prospect due to its robust balance sheet and market position, trading at a discount compared to the Russell 3000® Value Index.
https://finance.yahoo.com/healthcare/articles/elevance-health-elv-fell-amid-134222129.html